AG00266D

1786-81-8 | 2-(Propylamino)-o-propionotoluidide hydrochloride

Chemical structure of 2-(Propylamino)-o-propionotoluidide hydrochloride, CAS 1786-81-8
AG00266D
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 1786-81-8
Catalog Number AG00266D(AGN-PC-0QBEMU)
Chemical Name 2-(Propylamino)-o-propionotoluidide hydrochloride
EC Number 217-244-0
IUPAC Name N-(2-methylphenyl)-2-(propylamino)propanamide;hydrochloride
InChI InChI=1S/C13H20N2O.ClH/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2;/h5-8,11,14H,4,9H2,1-3H3,(H,15,16);1H
InChI Key BJPJNTKRKALCPP-UHFFFAOYSA-N
MDL Number MFCD00079279
Molecular Formula C13H21ClN2O
Molecular Weight 256.7716
NSC Number 758432
SMILES CCCNC(C(=O)Nc1ccccc1C)C.Cl
Synonyms
Citanest, Citanest Octapressin, Prilocaine, Prilocaine Hydrochloride, Propitocaine, Xylonest, Prilocaine hydrochloride, 1786-81-8, Propitocaine hydrochloride, Prilocaine HCl, Xylonest, Prilocaine chloride, Citanest hydrochloride, Citanest plain, Astra 1512, N-(2-Methylphenyl)-2-(propylamino)propanamide hydrochloride, Prilocaine (hydrochloride), 2-(Propylamino)-, 2-(Propylamino)-o-propionotoluidide hydrochloride, L-67, EINECS 217-244-0, MFCD00079279, MLS000069690, 2-(Propylamino)-N-(o-tolyl)propanamide hydrochloride, 2-(Propylamino)-o-propionotoluidide monohydrochloride, alpha-Propylamine-2-methyl-propionanilide hydrochloride, o-Propionotoluidide, 2-(propylamino)-, monohydrochloride, SMR000058506, Propanamide, N-(2-methylphenyl)-2-(propylamino)-, monohydrochloride, DSSTox_CID_11956, DSSTox_RID_78897, DSSTox_GSID_31956, 878791-35-6, Q-201619, N-(2-methylphenyl)-2-(propylamino)propanamide;hydrochloride, CHEBI:32053, SR-01000076094, L 67, Propitocaine HCl, Prilocaine hydrochloride [USAN], Prilocaine, HCl, Citanest (TN), Prestwick_616, Prilocaine hydrochloride [USAN:USP], L 67 Hydrochloride, prilocaine-hydrochloride, Propitocainehydrochloride, Opera_ID_480, AC1L3NJV, NCGC00016594-01, CAS-1786-81-8, MLS002222230, MLS002548864, ARONIS24439, SCHEMBL330180, SPECTRUM1503270, 2-(Propylamino)-N-(o-tolyl)propionamide Hydrochloride, Prilocaine hydrochloride (USP), CHEMBL1200586, DTXSID2031956, CTK8G2574, HY-B0137A, Propitocaine hydrochloride (JAN), BBC/603, EBD2408, HMS1568H19, HMS1922O15, Pharmakon1600-01503270, Prilocaine HCl (Propitocaine HCl), ACT04757, BCP22337, ZX-AS004804, Tox21_110513, Tox21_501005, BG0296, CCG-39327, DT1296, FC1266, GP0348, NSC758432, AKOS015895106, Propanamide, N-(2-methylphenyl)-2-(propylamino)-, hydrochloride (1:1), Tox21_110513_1, AC-2099, API0003927, CS-1930, KS-5024, LP01005, LS-2121, MCULE-7993425453, NC00474, NSC-758432, NCGC00015860-06, NCGC00094299-01, NCGC00094299-02, NCGC00094299-03, NCGC00094299-04, NCGC00094299-05, NCGC00261690-01, AN-14287, BC209185, CPD000058506, Prilocaine hydrochloride, >=98% (TLC), SAM002264640, SC-22683, SY066795, BCP0726000006, AB0005494, AB1004860, AX8040365, LS-119349, LS-119350, LS-119351, EU-0101005, FT-0633840, P2038, ST24049036, ST51015112, MFCD00079279 (97%), D01243, EN300-188472, J10292, M-1534, P 9547, 2-(Propylamino)-m-propionotoluidide Hydrochloride, 2-(propylamino)-N-o-tolylpropanamide hydrochloride, 786P818, A812391, I06-0422, SR-01000076094-1, SR-01000076094-6, N-(2-methylphenyl)-N2-propylalaninamide hydrochloride, N-(o-tolyl)-2-(propylamino)propanamide hydrochloride, N-(2-methylphenyl)-2-(propylamino)propanamide, chloride, PRILOCAINE HYDROCHLORIDE (PRILOCAINE (721-50-6)), Prilocaine hydrochloride, meets USP testing specifications, N-(2-Methylphenyl)-2-(propylamino)-propanamide hydrochloride, Prilocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard, Prilocaine for peak identification, European Pharmacopoeia (EP) Reference Standard, Prilocaine hydrochloride, United States Pharmacopeia (USP) Reference Standard, 2-(Propylamino)-o-propionotoluidide hydrochloride; N-(2-Methylphenyl)-2-(propylamino)-propanamide hydrochloride, Citanest, Citanest Forte, Mixture Name, UNII-MJW015BAPH, MJW015BAPH, C13H21ClN2O, C13H20N2O.HCl, C13-H20-N2-O.Cl-H, CID92163, ACN-028686, CS-P-00474, N-(3-Methylphenyl)-2-(propylamino)propanamide Hydrochloride, Prilocaine hydrochloride, 99%, a local anesthetic of the amino amide type - 1G 1g, 4H-Pyrano[2,3-b][1,4]benzodioxin-4-one, decahydro-4a,7,9-trihydroxy- 2-methyl-6,8-bis(methylamino)-, (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited